3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Conditions
Uterine Cervical Dysplasia
14
Uterine Cervical Neoplasms
4
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Precancerous Conditions
2
Papillomavirus Infections
2
HIV Infections
2
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Vaginal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
16
Papillomavirus Vaccines
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Vaccines
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Specimen Handling
4
Blood Specimen Collection
4
Watchful Waiting
3
Vaginal Smears
3
Patient Navigation
3
Engerix-B
3
Educational Status
3
fludarabine phosphate
2
fludarabine
2
artesunic acid
2
artemisinin
2
aldesleukin
2
Vaccines, Synthetic
2
Standard of Care
2
Practice Guidelines as Topic
2
Polymerase Chain Reaction
2
Mass Screening
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
GX-188 vaccine
2
Early Intervention, Educational
2
Data Collection
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Imiquimod
×
Gynecologic
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts